Inventor
Blair T. Lapointe
Inventor
Brookline, MA, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
Y02ATechnologies for adaptation to climate change18%
PatentTitleYear
10,745,364Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease202010,689,369Substituted indazole compounds as RORgammaT inhibitors and uses thereof202010,584,121Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof202010,377,768Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease201910,344,000Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof201910,287,272Substituted indazole compounds as RORgammaT inhibitors and uses thereof201910,221,142Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof201910,221,146Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease201910,196,3544-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof20199,809,561'Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease'20179,745,265'4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof'20179,663,522'3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof'20179,663,502'2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease'20179,657,033'Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease'20179,556,168'N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof'20179,487,490'3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof'2016Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2016–2020Patents assigned to MERCK SHARP & DOHME (16)· patent assignee history
2016–2020Based in Brookline, MA, US· patent location history
2017–2020Patents assigned to LYCERA CORP (6)· patent assignee history
2017–2019Based in Boston, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 16 | 2016–2020 |
| LYCERA CORP | 6 | 2017–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Brookline, Massachusetts, US | 13 | 2016–2020 |
| Boston, Massachusetts, US | 3 | 2017–2019 |